Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
The American Journal of Gastroenterology
|
August 26, 1998
Visualization of intestinal splenosis by somatostatin receptor scintigraphy
A Kurtaran, T Pangerl, C Scheuba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 26, 1998
Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma
A Kurtaran, C Scheuba, K Kaserer, et al.
Wiener Klinische Wochenschrift
|
January 1, 1995
[Thrombocyte function of healthy probands taking 50 mg of acetylsalicylic acid per day]
H Sinzinger, H Kritz, C Pirich, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 18, 2001
FDG-PET in adrenocortical carcinoma
A Becherer, H Vierhapper, C Pötzi, et al.
Scandinavian Journal of Gastroenterology
|
February 15, 2002
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression
W C Fiebiger, W Scheithauer, T Traub, et al.
Nuklearmedizin. Nuclear Medicine
|
October 14, 2004
Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy
S Ozer, G Dobrozemsky, O Kienast, et al.
The American Journal of Gastroenterology
|
May 16, 2000
An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis
A Kurtaran, S Ofluoglu, T Traub, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1997
Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis
A Kurtaran, M Raderer, C Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy
S Li, M Peck-Radosavljevic, O Kienast, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 1997
Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease
S R Li, Q Yang, E Koller, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
The American Journal of Gastroenterology
|
August 26, 1998
Visualization of intestinal splenosis by somatostatin receptor scintigraphy
A Kurtaran, T Pangerl, C Scheuba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 26, 1998
Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma
A Kurtaran, C Scheuba, K Kaserer, et al.
Wiener Klinische Wochenschrift
|
January 1, 1995
[Thrombocyte function of healthy probands taking 50 mg of acetylsalicylic acid per day]
H Sinzinger, H Kritz, C Pirich, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 18, 2001
FDG-PET in adrenocortical carcinoma
A Becherer, H Vierhapper, C Pötzi, et al.
Scandinavian Journal of Gastroenterology
|
February 15, 2002
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression
W C Fiebiger, W Scheithauer, T Traub, et al.
Nuklearmedizin. Nuclear Medicine
|
October 14, 2004
Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy
S Ozer, G Dobrozemsky, O Kienast, et al.
The American Journal of Gastroenterology
|
May 16, 2000
An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis
A Kurtaran, S Ofluoglu, T Traub, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1997
Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis
A Kurtaran, M Raderer, C Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy
S Li, M Peck-Radosavljevic, O Kienast, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 1997
Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease
S R Li, Q Yang, E Koller, et al.
Page
of 7